{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:53Z","timestamp":1789907693009,"version":"4.0.1"},"reference-count":107,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Androgenetic alopecia, or male\/female pattern baldness, is the most common type of progressive hair loss disorder. The aim of this study was to review recent advances in non\u2010surgical treatments for androgenetic alopecia and identify the most effective treatments. A network meta\u2010analysis (\n                    <jats:styled-content style=\"fixed-case\">NMA<\/jats:styled-content>\n                    ) was conducted of the available literature of the six most common non\u2010surgical treatment options for treating androgenetic alopecia in both men and women; dutasteride 0.5\u00a0mg, finasteride 1\u00a0mg, low\u2010level laser therapy (\n                    <jats:styled-content style=\"fixed-case\">LLLT<\/jats:styled-content>\n                    ), minoxidil 2%, minoxidil 5% and platelet\u2010rich plasma (\n                    <jats:styled-content style=\"fixed-case\">PRP<\/jats:styled-content>\n                    ). Seventy\u2010eight studies met the inclusion criteria, and 22 studies had the data necessary for a network meta\u2010analysis. Relative effects show\n                    <jats:styled-content style=\"fixed-case\">LLLT<\/jats:styled-content>\n                    as the superior treatment. Relative effects show\n                    <jats:styled-content style=\"fixed-case\">PRP<\/jats:styled-content>\n                    , finasteride 1\u00a0mg (male), finasteride 1\u00a0mg (female), minoxidil 5%, minoxidil 2% and dutasteride (male) are approximately equivalent in mean change hair count following treatment. Minoxidil 5% and minoxidil 2% reported the most drug\u2010related adverse events (\n                    <jats:italic>n\u00a0=\u00a0<\/jats:italic>\n                    45 and\n                    <jats:italic>n\u00a0=\u00a0<\/jats:italic>\n                    23, respectively). The quality of evidence of minoxidil 2% vs. minoxidil 5% was high; minoxidil 5% vs. placebo was moderate; dutasteride (male) vs. placebo, finasteride (female) vs. placebo, minoxidil 2% vs. placebo and minoxidil 5% vs.\n                    <jats:styled-content style=\"fixed-case\">LLLT<\/jats:styled-content>\n                    was low; and finasteride (male) vs. placebo,\n                    <jats:styled-content style=\"fixed-case\">LLLT<\/jats:styled-content>\n                    vs. sham,\n                    <jats:styled-content style=\"fixed-case\">PRP<\/jats:styled-content>\n                    vs. placebo and finasteride vs. minoxidil 2% was very low. Results of this\n                    <jats:styled-content style=\"fixed-case\">NMA<\/jats:styled-content>\n                    indicate the emergence of novel, non\u2010hormonal therapies as effective treatments for hair loss; however, the quality of evidence is generally low. High\u2010quality randomized controlled trials and head\u2010to\u2010head trials are required to support these findings and aid in the development of more standardized protocols, particularly for\n                    <jats:styled-content style=\"fixed-case\">PRP<\/jats:styled-content>\n                    . Regardless, this analysis may aid physicians in clinical decision\u2010making and highlight the variety of non\u2010surgical hair restoration options for patients.\n                  <\/jats:p>","DOI":"10.1111\/jdv.15081","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T04:01:49Z","timestamp":1527134509000},"page":"2112-2125","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Efficacy of non\u2010surgical treatments for androgenetic alopecia: a systematic review and network meta\u2010analysis"],"prefix":"10.1111","volume":"32","author":[{"given":"A.K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc. London Canada"},{"name":"Division of Dermatology Department of Medicine University of Toronto Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.R.","family":"Mays","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Dotzert","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Versteeg","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc. London Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.H.","family":"Shear","sequence":"additional","affiliation":[{"name":"Division of Dermatology Department of Medicine University of Toronto Toronto Canada"},{"name":"Division of Dermatology Sunnybrook Health Sciences Centre Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Piguet","sequence":"additional","affiliation":[{"name":"Division of Dermatology Department of Medicine University of Toronto Toronto Canada"},{"name":"Division of Infection and Immunity Cardiff University School of Medicine Cardiff United Kingdom"},{"name":"Division of Dermatology Women's College Hospital Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2002.01086.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12335779"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-6-1012"},{"key":"e_1_2_6_5_1","first-page":"339","article-title":"Confirmation of the association between male pattern baldness and the androgen receptor gene","volume":"15","author":"Levy\u2010Nissenbaum E","year":"2005","journal-title":"Eur J Dermatol EJD"},{"key":"e_1_2_6_6_1","unstructured":"PROPECIA\u00ae (finasteride) tablets for oral use [Internet].Drugs@FDA: FDA Approved Drug Products.2014[cited 2017 Dec 21]. Available from:https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=020788"},{"key":"e_1_2_6_7_1","unstructured":"Johnson and Johnson Inc.Rogaine (minoxidil) Product Monograph.2011."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000901"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05785.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12326964"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12334249"},{"key":"e_1_2_6_12_1","unstructured":"HAIR REGROWTH FORMULA Minoxidil Topical Solution USP 20\u00a0mg\/mL (2% w\/v) [Internet].Government of Canada.2011. Available from:https:\/\/pdf.hres.ca\/dpd_pm\/00033538.PDF"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1179712"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1999.79.4.1283"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.2001.81.1.449"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11317"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2014.03.004"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020408"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2005.23.3"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2004.07.033"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0722.2000.00783.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-017-2385-5"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.054"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.04.002"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"e_1_2_6_26_1","unstructured":"Assessing Risk of Bias in Included Studies | Cochrane Bias [Internet]. [cited 2017 Dec 28]. Available from:\/bias\/assessing\u2010risk\u2010bias\u2010included\u2010studies"},{"key":"e_1_2_6_27_1","unstructured":"vanValkenhoefG TervonenT ZwinkelsT deBrockB HillegeH.ADDIS: a decision support system for evidence\u2010based medicine [Internet].2012[cited 2012 Aug 29]. Available from:http:\/\/drugis.org\/files\/addis-dss.pdf"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(88)90086-7"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000665"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb00006.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546630252775171"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1376094"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1326609"},{"key":"e_1_2_6_34_1","first-page":"874","article-title":"A phase III, multicenter, parallel\u2010design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss","volume":"15","author":"Bergfeld W","year":"2016","journal-title":"J Drugs Dermatol JDD"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06295.x"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00804.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04551-X"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/760709"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1159\/000248902"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1990.tb00644.x"},{"key":"e_1_2_6_41_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archderm.1985.01660020055017","article-title":"Topical minoxidil therapy in hereditary androgenetic alopecia","volume":"121","author":"Villez RL","year":"1985","journal-title":"Arch Dermatol"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70085-1"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1994.01690030035005"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1159\/000481141"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb00004.x"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22684"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.09.018"},{"key":"e_1_2_6_48_1","first-page":"155","article-title":"Comparison of the efficacy of topical minoxidil 5% and adenosine 0.75% solutions on male androgenetic alopecia and measuring patient satisfaction rate","volume":"21","author":"Faghihi G","year":"2013","journal-title":"Acta Dermatovenerol Croat ADC"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000001114"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2015-0107"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.049"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.45220"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1159\/000375320"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12246"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1993.tb02755.x"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0060-6"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70092-9"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70007-6"},{"key":"e_1_2_6_59_1","first-page":"38","article-title":"Long\u2010term (5\u2010year) multinational experience with finasteride 1\u00a0mg in the treatment of men with androgenetic alopecia","volume":"12","author":"Finasteride Male Pattern Hair Loss Study Group","year":"2002","journal-title":"Eur J Dermatol EJD"},{"key":"e_1_2_6_60_1","first-page":"247","article-title":"Finasteride in the treatment of Japanese men with male pattern hair loss","volume":"14","author":"Kawashima M","year":"2004","journal-title":"Eur J Dermatol EJD"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00314.x"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12200"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.123.11.1483"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70093-0"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22173"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22277"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200929050-00001"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb03410.x"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70081-2"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.06.014"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2016.1225963"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70138-2"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.124088"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.05.007"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.04.012"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.10.027"},{"key":"e_1_2_6_77_1","first-page":"15","article-title":"Rosemary oil vs minoxidil 2% for the treatment of androgenetic alopecia: a randomized comparative trial","volume":"13","author":"Panahi Y","year":"2015","journal-title":"Skinmed"},{"key":"e_1_2_6_78_1","first-page":"276","article-title":"Therapeutic effects of minoxidil high extra combination therapy in patients with androgenetic alopecia","volume":"10","author":"Pazoki\u2010Toroudi H","year":"2012","journal-title":"Skinmed"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb00003.x"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(88)70105-X"},{"key":"e_1_2_6_81_1","first-page":"139","article-title":"A randomized double blind study of the effect of finasteride on hair growth in male patients of androgenetic alopecia","volume":"50","author":"Prasad HR","year":"2005","journal-title":"Indian J Dermatol"},{"key":"e_1_2_6_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12514348"},{"key":"e_1_2_6_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70006-X"},{"key":"e_1_2_6_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.001"},{"key":"e_1_2_6_85_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120537"},{"key":"e_1_2_6_86_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.107953"},{"key":"e_1_2_6_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000883"},{"key":"e_1_2_6_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70087-5"},{"key":"e_1_2_6_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70091-7"},{"key":"e_1_2_6_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)80052-8"},{"key":"e_1_2_6_91_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201202500435"},{"key":"e_1_2_6_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00881.x"},{"key":"e_1_2_6_93_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S43481"},{"key":"e_1_2_6_94_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.9.1219-b"},{"key":"e_1_2_6_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70090-5"},{"key":"e_1_2_6_96_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.188652"},{"key":"e_1_2_6_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70086-3"},{"key":"e_1_2_6_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(88)90088-0"},{"key":"e_1_2_6_99_1","first-page":"32","article-title":"Finasteride improves male pattern hair loss in a randomized study in identical twins","volume":"12","author":"Stough DB","year":"2002","journal-title":"Eur J Dermatol EJD"},{"key":"e_1_2_6_100_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2007.00297.x"},{"key":"e_1_2_6_101_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12357"},{"key":"e_1_2_6_102_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03780.x"},{"key":"e_1_2_6_103_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb04251.x"},{"key":"e_1_2_6_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jidsp.5640230"},{"key":"e_1_2_6_105_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14223"},{"key":"e_1_2_6_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1837"},{"key":"e_1_2_6_107_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12617"},{"key":"e_1_2_6_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.15081","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:17:46Z","timestamp":1694737066000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.15081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":107,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1111\/jdv.15081"],"URL":"https:\/\/doi.org\/10.1111\/jdv.15081","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"2018-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}